Search

Search Constraints

You searched for: Author/Creator Gelderblom, Hans

Search Results

1. 2022-RA-1395-ESGO Quality assessment as part of the quality assurance of a regional gynecological comprehensive cancer care network in the Netherlands. (20th October 2022)

2. 2022-RA-1571-ESGO 'Mirror conversation' as part of the quality assurance of a regional gynaecological comprehensive cancer care network in the Netherlands. (20th October 2022)

3. A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy. (January 2019)

5. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors. Issue 1 (15th March 2020)

6. A multidisciplinary approach to giant cell tumors of tendon sheath and synovium—A critical appraisal of literature and treatment proposal. Issue 4 (17th July 2012)

7. A novel colony‐stimulating factor 1 (CSF1) translocation  involving human endogenous retroviral element in a tenosynovial giant cell tumor. Issue 4 (5th January 2023)

8. A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas. Issue 14 (29th April 2019)

9. A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities. (September 2015)

10. A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma. (2nd December 2021)